Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Simó

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Diabetologia|March 4, 2011
Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activationM Villarroel, M Garcia-Ramírez, L Corraliza, et al.
Medicina Clinica|December 22, 1999
[Lipoprotein (a) and the evaluation of low density cholesterol by the Friedewald formula: a new problem for an old equation]C Hernández, P Chacón, L García-Pascual, et al.
Thrombosis Research|August 18, 2000
Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patientsC Hernández, P Chacón, L García-Pascual, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2002
Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathyC Hernández, A Lecube, R M Segura, et al.
Diabetes Care|June 17, 2000
Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control studyR Burgos, C Mateo, A Cantón, et al.
Medicina Clinica|May 28, 1994
[Pheochromocytoma and Von-Hippel-Lindau disease]R Burgos Peláez, R Simó Canonge, C Hernández-Pascual, et al.
Revista Clinica Espanola|December 1, 1988
[Empty sella turcica associated with diabetes insipidus]J Mesa Manteca, R Simó Canonge, G Obiols Alfonso, et al.
European Journal of Clinical Investigation|June 1, 1997
Relationship between lipoprotein(a) phenotypes and albumin excretion rate in non-insulin-dependent diabetes mellitus: protective effect of 'null' phenotype?C Hernández, R Simó, P Chacón, et al.
Medicina Clinica|January 14, 1989
[Ketoconazole in the treatment of adrenal carcinoma]J Mesa Manteca, S Boluda Monzó, R Simó Canonge, et al.
Cytokine|February 8, 2011
TNF-α system and lung function impairment in obesityA Lecube, G Sampol, X Muñoz, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Diabetologia|March 4, 2011
Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activationM Villarroel, M Garcia-Ramírez, L Corraliza, et al.
Medicina Clinica|December 22, 1999
[Lipoprotein (a) and the evaluation of low density cholesterol by the Friedewald formula: a new problem for an old equation]C Hernández, P Chacón, L García-Pascual, et al.
Thrombosis Research|August 18, 2000
Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patientsC Hernández, P Chacón, L García-Pascual, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2002
Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathyC Hernández, A Lecube, R M Segura, et al.
Diabetes Care|June 17, 2000
Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control studyR Burgos, C Mateo, A Cantón, et al.
Medicina Clinica|May 28, 1994
[Pheochromocytoma and Von-Hippel-Lindau disease]R Burgos Peláez, R Simó Canonge, C Hernández-Pascual, et al.
Revista Clinica Espanola|December 1, 1988
[Empty sella turcica associated with diabetes insipidus]J Mesa Manteca, R Simó Canonge, G Obiols Alfonso, et al.
European Journal of Clinical Investigation|June 1, 1997
Relationship between lipoprotein(a) phenotypes and albumin excretion rate in non-insulin-dependent diabetes mellitus: protective effect of 'null' phenotype?C Hernández, R Simó, P Chacón, et al.
Medicina Clinica|January 14, 1989
[Ketoconazole in the treatment of adrenal carcinoma]J Mesa Manteca, S Boluda Monzó, R Simó Canonge, et al.
Cytokine|February 8, 2011
TNF-α system and lung function impairment in obesityA Lecube, G Sampol, X Muñoz, et al.
Pageof 15